pre-exposure prophylaxis news - Search News

Newsweek on MSN · 1d

HIV Breakthrough as New Injection 89% More Effective Than PrEP

"PrEP reduces the risk of getting HIV from sex by about 99 percent when taken as prescribed. Although there is less information about how effective PrEP pills are among people who inject drugs, we know that PrEP pills reduce the risk of getting HIV by at least 74 percent when taken as prescribed," the CDC says.

HealthDay on MSN · 11h

Twice-Yearly Injection 96% Effective in Preventing HIV Infection

People whose partners have HIV must remember to take antiretroviral pills every single day or risk infection themselves. But researchers have come up with a way to avoid that daily hassle – an injectable drug that patients would only have to receive twice a year.

Medical Xpress on MSN · 1d

New HIV prevention injection offers 96% protection

For oral medications that prevent new HIV infection to be effective, the patient must take certain actions, including attending doctor's visits every three months and – most importantly – consistency.

GlobalData on MSN · 12h

Gilead’s twice-yearly lenacapavir shows promise in HIV prevention trial

The Phase III Purpose 2 trial compared the safety and efficacy of twice-yearly subcutaneous lenacapavir for pre-exposure prophylaxis (PrEP) against once-daily oral Truvada.

TAG24 NEWS on MSN11h

Report confirms fewest new HIV cases since late 1980s – but experts warn decline is too slow

Fewer people contracted HIV last year than at any point since the rise of the disease in the late 1980s, the United Nations ...

17hon MSN

HIV infections can be prevented – why some people act to protect themselves, and others don’t

People are at the heart of the HIV pandemic, so it’s important to understand how they make protection decisions.

Clinical trial at Emory University reveals twice-yearly injection to be 96% effective in HIV prevention

These daily oral antiretrovirals, more commonly referred to as PrEP (pre-exposure prophylaxis), such as Truvada®, are ...

22h

Twice-Yearly Injection Reduces Risk of HIV Infection by 96%

For oral medications that prevent new HIV infection to be effective, the patient must take certain actions, including ...

Too Old to Operate2d

Q&A: Addressing Barriers to Long-Acting Injectable PrEP for Transgender Women

Research shows many transgender women in the U.S. express interest in long-acting injectable PrEP but face barriers to ...

1d

'Huge relief' as new drug found to effectively prevent HIV infection

A vaccination with the drug lenacapavir offers an effective protection against a HIV infection, according to newly published ...

8d

How Gilead Is Driving Global Health Equity And Innovation

Dan O’Day drives Gilead's mission to end HIV worldwide, pioneering treatments like lenacapavir and championing global health ...

1d

Gilead announces PURPOSE 2 trial data published in NEJM

Gilead (GILD) announced The New England Journal of Medicine, or NEJM, published the full results from the company’s pivotal Phase 3 PURPOSE 2 ...

Gilead Sciences: Designing Inclusive Clinical Trials in an Effort To Upend the HIV Epidemic

Lead PURPOSE researcher Moupali Das, Vice President, Clinical Development, HIV Prevention & Pediatrics, designed the PURPOSE ...

The Kenya Times on MSN1d

Bill Gates Opens Up on Finding Lifetime HIV Vaccine

U.S. philanthropist and entrepreneur Bill Gates has opened up about the search for a lifetime HIV vaccine, rather than one ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results